Description

Trametinib is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity.It inhibits MEK1 and MEK2. Trametinib had good results for metastatic melanoma carrying the BRAF V600E mutation in a phase III clinical trial.
Share ThisFacebookTwitterWhatsAppPinterestShare This

Reviews
Ratings

0.0

0 Product Ratings
5
0
4
0
3
0
2
0
1
0

Review this product

Share your thoughts with other customers

Write a review

Reviews

There are no reviews yet.